Namiki T, Yokoyama Y, Hashi H, Oda R, Jibiki A, Kawazoe H, Matsumoto K, Suzuki S, Nakamura T. Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended-Spectrum β-lactamase producing Enterobacterales (ESBL-E). Pharmacotherapy. 2024. 44. 149-162
Nishino H, Kawazoe H, Sekiguchi M, Jibiki A, Yokoyama Y, Suzuki S, Nakamura T. Drug Repositioning Study on the Antiemetic Efficacy of Anamorelin for Cisplatin-Induced Nausea and Vomiting in Rats. BPB Reports. 2024. 7. 1. 1-7
Maeda-Minami A, Kawamoto A, Yoshino T, Yokoyama Y, Suzuki S, Horiba Y, Nakamura T, Mimura M, Watanabe K. Patient prognosis and prediction model for taking Kampo formulas in dysmenorrhea: An observational study. Medicine. 2023. 102. 48
Igarashi Y, Kojima N, Takemura W, Liu X, Morita T, Mizukami Y, Enoki Y, Taguchi K, Yokoyama Y, Nakamura T, et al. In vivo pharmacokinetics/pharmacodynamics profiles for appropriate doses of cefditoren pivoxil against S. pneumoniae in murine lung-infection model. Pharmaceutical Research. 2023
2022/02 - Best Poster Presenter <Student> Ingenol mebutate inhibits proliferation of pancreatic cancer cells at lower concentration than other established antitumor agents for pancreatic cancer
2022/02 - Best Oral Presenter <Student> Novel assay for simultaneous quantification of parent compounds and active metabolites of second-/third-generation EGFR-TKIs for clinical application